Sort by
Refine Your Search
-
Listed
-
Country
-
Employer
- Pfizer
- Henkel
- Arizona State University’s Biodesign Institute
- Baylor College of Medicine
- Faculté de biologie et de médecine de Lausanne
- Log10
- National Institute of Allergy and Infectious Diseases (NIAID)
- Smithsonian Institution Human Resources
- University of California, Irvine
- University of Louisville
-
Field
-
UNIVERSITY OF CALIFORNIA IRVINE Director, Master of Science in Biomedical and Translational Science (MS-BATS) Program Irvine, CA POSITION DESCRIPTION The University of California, Irvine (UCI
-
. Prepare activity and budget reports for use by the principal investigator (PI). Partner with Chief & TCH department administrator on annual budget. Participate in and represent Congenital Heart Surgery on
-
JOB SUMMARY The Site Care Partner is the main Pfizer point of contact for investigative sites as well as accountable for safeguarding the quality and patient safety at the investigator site
-
Role Summary The Site Care Partner is the main Pfizer point of contact for investigative sites, responsible for building and retaining relationships from site activation through the lifecycle
-
Faculté de biologie et de médecine de Lausanne | Lausanne, Canton de Vaud | Switzerland | about 1 month ago
. Main missions: Develop and optimize standard operating procedures for T-cell design and expansion, and for the adoption of T-cell transfer. Assume responsibility for teaching students in biology or
-
projects to expand and maintain the system. Collaborating with the Infrastructure lead on strategy, methodologies, master planning and documentation of the PI data historian to align with industry best
-
reports. Motivate personnel by setting high standards, encourage teamwork. Clear, unambiguous communication is critical. Primary contact for all personnel issues occurring within the department. Responsible
-
directly impact patients. What You Will Achieve The primary responsibility of this position is to provide logistical support to clinical study teams for Vaccine Research and Development (VRD) clinical and
-
first in human (FIH) through proof of concept (PoC) studies, including proof of mechanism (PoM) and early signals of efficacy (ESoE) studies in a given therapeutic area. The primary therapeutic areas
-
deliverables remain on target to meet internal and external deadlines. The GLL serves as the GLM primary point of contact for Labeling Team members (e.g. Regulatory Strategist, Safety Risk Lead, Functional Line